chr4-107895572-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001375905.1(SGMS2):c.19G>C(p.Ala7Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,613,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A7E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001375905.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SGMS2 | NM_001375905.1 | c.19G>C | p.Ala7Pro | missense_variant | 3/7 | ENST00000690982.1 | |
CYP2U1-AS1 | NR_125929.1 | n.150-1935C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SGMS2 | ENST00000690982.1 | c.19G>C | p.Ala7Pro | missense_variant | 3/7 | NM_001375905.1 | P1 | ||
CYP2U1-AS1 | ENST00000656249.1 | n.290-1935C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250110Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135152
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461266Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726896
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74316
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.19G>C (p.A7P) alteration is located in exon 2 (coding exon 1) of the SGMS2 gene. This alteration results from a G to C substitution at nucleotide position 19, causing the alanine (A) at amino acid position 7 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | ClinVar contains an entry for this variant (Variation ID: 1973913). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with SGMS2-related conditions. This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 7 of the SGMS2 protein (p.Ala7Pro). This variant is present in population databases (rs769608601, gnomAD 0.02%). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at